0001567619-21-020591.txt : 20211116
0001567619-21-020591.hdr.sgml : 20211116
20211116175435
ACCESSION NUMBER: 0001567619-21-020591
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211115
FILED AS OF DATE: 20211116
DATE AS OF CHANGE: 20211116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jacobs Jeffrey W
CENTRAL INDEX KEY: 0001611193
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36485
FILM NUMBER: 211417655
MAIL ADDRESS:
STREET 1: C/O ARDELYX, INC.
STREET 2: 34175 ARDENWOOD BLVD, SUITE 100
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARDELYX, INC.
CENTRAL INDEX KEY: 0001437402
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
BUSINESS PHONE: 510-745-7047
MAIL ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
FORMER COMPANY:
FORMER CONFORMED NAME: NTERYX INC
DATE OF NAME CHANGE: 20080611
4
1
doc1.xml
FORM 4
X0306
4
2021-11-15
0
0001437402
ARDELYX, INC.
ARDX
0001611193
Jacobs Jeffrey W
C/O ARDELYX, INC.
34175 ARDENWOOD BLVD, SUITE 200
FREMONT
CA
94555
0
1
0
0
Chief Scientific Officer
Common Stock
2021-11-15
4
S
0
5000
1.13
D
125237
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2021.
/s/ Elizabeth Grammer, Attorney-in-Fact for Jeffrey W. Jacobs
2021-11-16